EVAXION A/S (EVAX:NASDAQ)
$2.95 0.06 (2.0761%)
Analysed EVAXION A/S (EVAX:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
12-06-2026
yahoo.com
European Equities Traded in US as ADRs Rise in Thursday Trading
25-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
29-06-2026
yahoo.com
Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
01-07-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading
01-07-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
02-07-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
06-07-2026
yahoo.com
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
12-07-2026
yahoo.com
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
17-07-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading
27-07-2026
yahoo.com
What is the current price of EVAXION A/S (EVAX:NASDAQ)?
The current price of EVAXION A/S (EVAX:NASDAQ) is $2.95.
EVAXION A/S (EVAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of EVAXION A/S (EVAX:NASDAQ) since the previous trading day is $0.06.
EVAXION A/S (EVAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of EVAXION A/S (EVAX:NASDAQ) since the previous trading day is 2.0761%.
What is the most recent average sentiment score for EVAXION A/S (EVAX:NASDAQ)?
The most recent average sentiment score for EVAXION A/S (EVAX:NASDAQ) is 32 out of 100.
What is the most recent average sentiment for EVAXION A/S (EVAX:NASDAQ)?
The most recent sentiment for EVAXION A/S (EVAX:NASDAQ) is .
SEC-8K** Filing Available For EVAXION A/S (EVAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.